SecProbe.io

Stored correspondence activity detail
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

Correspondence Activity Detail

Acurx Pharmaceuticals, Inc. (ACXP) (CIK 0001736243) (ACXP)
Activity window: Nov. 12, 2025 to Nov. 11, 2026

Back View Correspondence Compare Probe Scores Download Probe Score CSV

Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.

Probe Score Breakdown

Current total
3.5 / 10
Correspondence-letter component
3.0
AI sentiment component
0.5
Keyword-match component
0.0
Signal-match component
0.0
Notable 8-K modifier
0.0

The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Oct. 24, 2026. Latest filing activity: May. 7, 2026. These dates describe different events.

Correspondence Filings
3
Keyword Matches
0
Latest Activity
May. 7, 2026
Related 8-Ks
0

Matched Signals

No stored keyword or signal matches were recorded for this activity window.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
May. 7, 2026 UPLOAD Neutral/Informational Low The SEC has communicated to Acurx Pharmaceuticals, Inc. that it will not review their registration statement filed on May 4, 2026. The letter emphasizes the company's responsibili… Read Filing EDGAR
May. 7, 2026 UPLOAD Neutral/Informational Low The SEC correspondence dated May 7, 2026, informs Acurx Pharmaceuticals, Inc. that their registration statement on Form S-1, filed on May 4, 2026, will not be reviewed. The SEC em… Read Filing EDGAR
May. 7, 2026 CORRESP Neutral/Informational Moderate Acurx Pharmaceuticals, Inc. has submitted a request for the acceleration of the effective date of its Registration Statement on Form S-1. The company aims for the registration to … Read Filing EDGAR
May. 7, 2026 CORRESP Neutral/Informational Moderate Acurx Pharmaceuticals, Inc. has submitted a request for the acceleration of the effective date of its Registration Statement on Form S-1. The company aims for the registration to … Read Filing EDGAR
Feb. 9, 2026 UPLOAD Neutral/Informational Low The SEC has communicated to Acurx Pharmaceuticals, Inc. that they will not review the company's registration statement filed on February 2, 2026. The SEC has reminded the company … Read Filing EDGAR
Feb. 9, 2026 CORRESP Neutral/Informational Moderate Acurx Pharmaceuticals, Inc. has submitted a request to the SEC for the acceleration of the effective date of its Registration Statement on Form S-1. The company aims for the regis… Read Filing EDGAR
Jan. 2, 2026 CORRESP Neutral/Informational Moderate Acurx Pharmaceuticals, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-3, originally filed on July 9, … Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in this activity window.